Meningitis C immunisation timing updated

Children should now receive three doses of meningitis C vaccine: at 4 months, at 12–13 months (in combination with HiB) and at around 14 years of age | SCIENCE PHOTO LIBRARY
Children should now receive three doses of meningitis C vaccine: at 4 months, at 12–13 months (in combination with HiB) and at around 14 years of age | SCIENCE PHOTO LIBRARY

The recommended timing of routine vaccination for meningitis C has changed following new guidance from the Joint Committee on Vaccination and Immunisation (JCVI).

The booster dose of the vaccine that was previously given at 4 months should now be given at the same time as the adolescent tetanus, diphtheria and polio vaccine (around 14 years), to extend protection into early adulthood. The aim of the change is to make the meningitis C immunisation programme more effective and offer greater overall public health protection.

For the initial dose at 3 months, Menjugate Kit or NeisVac-C should be given; Meningitec should not be used because a single dose given in infancy does not provide adequate protection. All three products are suitable for the adolescent booster dose. 

For a quick-reference summary of the routine childhood immunisation schedule, see the MIMS table.

View meningitis vaccine drug records

Letter to healthcare professionals

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

Update to meningitis C vaccine schedule

Update to meningitis C vaccine schedule

A time-limited meningitis C catch-up vaccination programme...

Bexsero: first meningitis B vaccine launched

Bexsero: first meningitis B vaccine launched

Novartis Vaccines has launched Bexsero for active immunisation...

Shingles vaccine programme launched

Shingles vaccine programme launched

The Department of Health, NHS England and Public Health...

Influenza vaccine added to childhood immunisation schedule

Influenza vaccine added to childhood immunisation schedule

From September 1st, all children aged 2 or 3 years...

Rotavirus vaccination programme launched

Rotavirus vaccination programme launched

Children under four months of age are to be vaccinated...

First vaccine for meningitis B 'imminent'

First vaccine for meningitis B 'imminent'

A new vaccine could help prevent the most common cause...



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more